Skip to main content
. Author manuscript; available in PMC: 2015 Jul 7.
Published in final edited form as: Hippocampus. 2010 Aug;20(8):911–916. doi: 10.1002/hipo.20760

FIGURE 3.

FIGURE 3

Effects of UFP-101, N/OFQ, and Ro64–6198 in the light-dark test. (a) and (a′) Effects of intrahippocampal infusions of acsf (n = 8) or UFP-101 (1 and 3 nmol, n = 8 per dose) on the percentage of time spent in the lit compartment and the number of transitions from the dark to light compartment, respectively. (b) and (b′) Effects of intrahippocampal infusions of acsf (n = 10) or N/OFQ (1 and 3 nmol, n = 8 and 9, respectively) on the percentage of time spent in the lit compartment and the number of transitions from the dark to the light compartment, respectively. (c) and (c′) Effects of intraperitoneal administration of vehicle (n = 16) or Ro64–6198 (0.1 and 0.3 mg/kg, n = 14 and 9, respectively) on the percentage of time spent in the lit compartment and the number of transitions, respectively. Data are presented as mean ± s.e.m. *Significantly different form corresponding control group, P < 0.05 ANOVA followed by Dunnett’s test.